Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Jan. 31 '26)

Image
By G.M.

 


    Am J Med

  1. CHENG Y, Ling Y, Scholten J, Atkins D, et al
    Patterns and trends in prevalent central nervous system stimulant use in US veterans with traumatic brain injury.
    Am J Med. 2026;139:170-180.
    PubMed         Abstract available


    BMC Pediatr

  2. AKAR A
    Rare disease mimicking multisystem inflammatory syndrome in children.
    BMC Pediatr. 2025;26:56.
    PubMed         Abstract available


    Cell

  3. PEKAR JE, Crespo-Bellido A, Lemey P, Bowman AS, et al
    Can H5N1 avian influenza in dairy cattle be contained in the US?
    Cell. 2026 Jan 23:S0092-8674(25)01483-7. doi: 10.1016/j.cell.2025.
    PubMed         Abstract available


    J Clin Microbiol

  4. XU X, Hull W, Plunkett D, Tu ZJ, et al
    Emergence of influenza A(H3N2) subclade K in northeast Ohio in autumn 2025.
    J Clin Microbiol. 2026 Jan 27:e0181325. doi: 10.1128/jcm.01813.
    PubMed        


    J Infect Dis

  5. ZHONG JC, Zhong S, Touyon L, Ho F, et al
    Repeat influenza vaccination effects in 2021/22 and 2022/23 in a community-based cohort in Hong Kong.
    J Infect Dis. 2026 Jan 28:jiag051. doi: 10.1093.
    PubMed         Abstract available

  6. YU X, Lee SL, Kwan MYW, Zhong S, et al
    Influenza vaccination effectiveness against influenza-associated hospitalization in children and the effects of repeated vaccination.
    J Infect Dis. 2026 Jan 23:jiag047. doi: 10.1093.
    PubMed         Abstract available

  7. DAULAGALA P, Cowling BJ, Yen HL
    Response to Letter to the Editor regarding the immunogenicity of enhanced influenza vaccines in inducing neuraminidase inhibition antibodies.
    J Infect Dis. 2026 Jan 24:jiag043. doi: 10.1093.
    PubMed        


    Lancet

  8. WHITAKER M, Elliott J, Gerard-Ursin I, Cooke GS, et al
    Profiling vaccine attitudes and subsequent uptake in 1.1 million people in England: a nationwide cohort study.
    Lancet. 2026 Jan 12:S0140-6736(25)01912-9. doi: 10.1016/S0140-6736(25)01912.
    PubMed         Abstract available


    PLoS Comput Biol

  9. TRIPATHY SS, Puthussery JV, Kapoor TS, Cirrito JR, et al
    Spatial variation in socio-economic vulnerability to Influenza-like Infection for the US population.
    PLoS Comput Biol. 2026;22:e1013839.
    PubMed         Abstract available


    PLoS One

  10. XU M, Shi J, Wang Y, Wu J, et al
    Exploring the role of the key gene TNFAIP3 between periodontitis and influenza A through bioinformatic analysis and molecular docking.
    PLoS One. 2026;21:e0340882.
    PubMed         Abstract available

  11. BAHR S, Batinic B, Collischon M
    Is working from home changing the meaning of work?
    PLoS One. 2026;21:e0340452.
    PubMed         Abstract available

  12. OYEDELE GJ, Vlaev I, Tildesley MJ
    Differential impacts of the COVID-19 pandemic on sociodemographic groups: A mathematical model framework.
    PLoS One. 2026;21:e0330273.
    PubMed         Abstract available

  13. REIF A, Guenther L, Taddicken M, Weingart P, et al
    Trust in science during the COVID-19 pandemic: A typology of internet users in South Africa.
    PLoS One. 2026;21:e0340881.
    PubMed         Abstract available

  14. ZHAO J, Yin J
    Empirical analysis of the correlation between China's Macroeconomic Market and Crude Oil Market based on mixed-frequency group factor model.
    PLoS One. 2026;21:e0336227.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  15. KIM AS, Ma K, Reinhardt CJ, Lazar DC, et al
    Integrated phenotypic screening and chemical proteomics identifies ETF1 ligands that modulate viral translation and replication.
    Proc Natl Acad Sci U S A. 2026;123:e2524108123.
    PubMed         Abstract available


    Vaccine

  16. CHANG TY, Jacobson M, Shah M, Pramanik R, et al
    Impact of reminder messages, with and without financial incentives, on influenza vaccination: A randomized trial in a California health system.
    Vaccine. 2026;75:128263.
    PubMed         Abstract available


    Virology

  17. ESAKI M, Okuya K, Onuma M, Ozawa M, et al
    Genetically distinct H5N2 high pathogenicity avian influenza virus isolated from a peregrine falcon on Amami-Oshima Island, Japan, harboring enhanced pathogenicity-associated amino acids in the PA protein.
    Virology. 2026;617:110794.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »